# Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

> **NCT01181960** · — · COMPLETED · sponsor: **Janssen Scientific Affairs, LLC** · enrollment: 1066 (actual)

## Conditions studied

- Schizophrenia
- Bipolar Disorder

## Interventions

- **DRUG:** Risperidone long acting injectable - New Starts
- **DRUG:** Risperidone long acting injectable - Continuous Users
- **DRUG:** Paliperidone Palmitate -New and Continuous Users
- **DRUG:** Other Antipsychotics - New Starts

## Key facts

- **NCT ID:** NCT01181960
- **Lead sponsor:** Janssen Scientific Affairs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 1066 (ACTUAL)
- **Last updated:** 2014-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181960, "Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01181960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*